Rapid identification of potent nonpeptidic serine protease inhibitors

被引:21
|
作者
Salisbury, Cleo M.
Ellman, Jonathan A. [1 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Ctr New Direct Organ Synth, Berkeley, CA 94720 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
关键词
hydrolases; inhibitors; nonpeptidic; proteases;
D O I
10.1002/cbic.200600081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Substrate activity screening was used to rapidly identify a novel and potent (kinact/Ki = 59000 M-1 S-1) nonpeptidic chymotrypsin inhibitor with Mw < 500. The inhibitor is more potent than the best reported tetrapeptidyl phosphonate chymotrypsin inhibitor and demonstrated selectivity over a panel of other serine proteases, including the closely related enzyme cathepsin G. © 2006 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:1034 / 1037
页数:4
相关论文
共 50 条
  • [41] Protein epitope mimetics: An innovative approach to the discovery of selective and highly potent serine protease inhibitors
    Sellier, O.
    Jung, F.
    DeMarco, S.
    Vrijbloed, J. W.
    Zumbrunn, J.
    Bisang, C.
    Decours, A.
    Moehle, K.
    Robinson, J. A.
    Henze, H.
    Ludin, C.
    Obrecht, D.
    Gombert, F. O.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 89 - 89
  • [42] Hydrogen bonding at serine protease active centers in the absence and presence of potent transition state inhibitors
    Bao, DH
    Huskey, WP
    Jordan, F
    Kettner, C
    FASEB JOURNAL, 1998, 12 (08): : A1363 - A1363
  • [43] A GENERIC APPROACH TO SERINE PROTEASE INHIBITORS
    GLOVER, GI
    SCHASTEEN, CS
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1858 - 1858
  • [44] Library of serine and cysteine protease inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (03) : 123 - 124
  • [45] Coumarin and isocoumarin as serine protease inhibitors
    Pochet, L
    Frédérick, R
    Masereel, B
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) : 3781 - 3796
  • [46] Engineering thermostability in serine protease inhibitors
    Im, H
    Ryu, MJ
    Yu, MH
    PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (04): : 325 - 331
  • [47] STRUCTURE-BASED DESIGN OF NOVEL NONPEPTIDIC HIV PROTEASE INHIBITORS
    LOVASZ, KD
    MORRIS, JK
    TOMICH, PK
    WATENPAUGH, KD
    HOWE, WJ
    DOLAK, LA
    ROMINES, KR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 25 - MEDI
  • [48] 5-ACYLOXYOXAZOLES AS SERINE PROTEASE INHIBITORS - RAPID INACTIVATION OF THROMBIN IN CONTRAST TO PLASMIN
    VALENTY, VB
    WOS, JD
    LOBO, AP
    LAWSON, WB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 88 (04) : 1375 - 1381
  • [49] QUANTITATION OF SERINE PROTEASE INHIBITORS BY SYNTHETIC PEPTIDE ANALOGS OF SERINE PROTEASE AND BY IMMUNOLOGICAL METHODOLOGIES
    PARVEZ, Z
    MESSMORE, HL
    FAREED, J
    MONCADA, R
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1063 - 1063
  • [50] Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease:: Towards smaller inhibitors
    Llinàs-Brunet, M
    Bailey, M
    Fazal, G
    Ghiro, E
    Gorys, V
    Goulet, S
    Halmos, T
    Maurice, R
    Poirier, M
    Poupart, MA
    Rancourt, J
    Thibeault, D
    Wernic, D
    Lamarre, D
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) : 2267 - 2270